Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Y Graeber

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|March 11, 2025
Intestinal current measurement detects age-dependent differences in CFTR function in rectal epitheliumSimon Y Graeber, Olaf Sommerburg, Yin Yu, et al.
JCI Insight|April 22, 2025
The potentiator ivacaftor is essential for pharmacological restoration of F508del-CFTR function and mucociliary clearance in cystic fibrosisAnita Balázs, Tihomir Rubil, Christine K Wong, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 17, 2017
Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseasesMirjam Stahl, Simon Y Graeber, Cornelia Joachim, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2021
Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretionJohanna J Salomon, Tobias Albrecht, Simon Y Graeber, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2016
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic FibrosisMirjam Stahl, Mark O Wielpütz, Simon Y Graeber, et al.
Mediators of Inflammation|February 16, 2018
Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic FibrosisSébastien Boutin, Martin Depner, Mirjam Stahl, et al.
Frontiers in Pharmacology|June 16, 2023
Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 yearsJulian Berges, Simon Y Graeber, Susanne Hämmerling, et al.
Macromolecular Rapid Communications|August 21, 2021
Polyglycerol-Based Mucus-Inspired HydrogelsAntara Sharma, Boonya Thongrom, Sumati Bhatia, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
The ENaC-overexpressing mouse as a model of cystic fibrosis lung diseaseZhe Zhou, Julia Duerr, Bjarki Johannesson, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic FibrosisMirjam Stahl, Eva Steinke, Simon Y Graeber, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|March 11, 2025
Intestinal current measurement detects age-dependent differences in CFTR function in rectal epitheliumSimon Y Graeber, Olaf Sommerburg, Yin Yu, et al.
JCI Insight|April 22, 2025
The potentiator ivacaftor is essential for pharmacological restoration of F508del-CFTR function and mucociliary clearance in cystic fibrosisAnita Balázs, Tihomir Rubil, Christine K Wong, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 17, 2017
Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseasesMirjam Stahl, Simon Y Graeber, Cornelia Joachim, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2021
Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretionJohanna J Salomon, Tobias Albrecht, Simon Y Graeber, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2016
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic FibrosisMirjam Stahl, Mark O Wielpütz, Simon Y Graeber, et al.
Mediators of Inflammation|February 16, 2018
Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic FibrosisSébastien Boutin, Martin Depner, Mirjam Stahl, et al.
Frontiers in Pharmacology|June 16, 2023
Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 yearsJulian Berges, Simon Y Graeber, Susanne Hämmerling, et al.
Macromolecular Rapid Communications|August 21, 2021
Polyglycerol-Based Mucus-Inspired HydrogelsAntara Sharma, Boonya Thongrom, Sumati Bhatia, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
The ENaC-overexpressing mouse as a model of cystic fibrosis lung diseaseZhe Zhou, Julia Duerr, Bjarki Johannesson, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic FibrosisMirjam Stahl, Eva Steinke, Simon Y Graeber, et al.
Pageof 6